CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 161 filers reported holding CYTOKINETICS INC in Q2 2020. The put-call ratio across all filers is 1.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $101,366,000 | +40.9% | 4,878,035 | +46.8% | 3.99% | +1.8% |
| Q3 2020 | $71,944,000 | +54.9% | 3,323,051 | -15.6% | 3.92% | -9.5% |
| Q1 2020 | $46,432,000 | -39.3% | 3,938,280 | -45.4% | 4.33% | -25.3% |
| Q4 2019 | $76,461,000 | +61.3% | 7,206,458 | +73.0% | 5.80% | +16.4% |
| Q3 2019 | $47,404,000 | -18.6% | 4,165,558 | -19.5% | 4.98% | -21.7% |
| Q2 2019 | $58,240,000 | +89.4% | 5,176,878 | +36.2% | 6.36% | +84.7% |
| Q1 2019 | $30,757,000 | +17.2% | 3,801,817 | -8.4% | 3.44% | +0.5% |
| Q4 2018 | $26,232,000 | -48.7% | 4,150,639 | -20.0% | 3.43% | -23.6% |
| Q3 2018 | $51,090,000 | +10.9% | 5,186,839 | -6.6% | 4.49% | -0.2% |
| Q2 2018 | $46,072,000 | +11.8% | 5,550,890 | -3.0% | 4.50% | +7.7% |
| Q1 2018 | $41,198,000 | -11.7% | 5,721,888 | 0.0% | 4.18% | -25.7% |
| Q4 2017 | $46,633,000 | +159.1% | 5,721,888 | +361.1% | 5.62% | +145.8% |
| Q3 2017 | $17,995,000 | -25.3% | 1,241,021 | -37.6% | 2.29% | -38.9% |
| Q2 2017 | $24,083,000 | -56.0% | 1,990,321 | -53.3% | 3.74% | -59.8% |
| Q1 2017 | $54,752,000 | -7.1% | 4,260,836 | -12.2% | 9.31% | -21.4% |
| Q4 2016 | $58,948,000 | +28.5% | 4,851,691 | -2.9% | 11.84% | +37.0% |
| Q3 2016 | $45,873,000 | -3.1% | 4,997,071 | +0.2% | 8.64% | -14.3% |
| Q2 2016 | $47,348,000 | +54.7% | 4,989,218 | +14.9% | 10.09% | +33.2% |
| Q1 2016 | $30,602,000 | +0.2% | 4,340,729 | +48.6% | 7.57% | +45.5% |
| Q4 2015 | $30,550,000 | +116.7% | 2,920,628 | +38.6% | 5.21% | +82.8% |
| Q3 2015 | $14,096,000 | -0.4% | 2,106,989 | 0.0% | 2.85% | +14.0% |
| Q2 2015 | $14,159,000 | -0.9% | 2,106,989 | 0.0% | 2.50% | -16.3% |
| Q1 2015 | $14,285,000 | -27.0% | 2,106,989 | -13.8% | 2.99% | -21.5% |
| Q4 2014 | $19,569,000 | +264.1% | 2,443,100 | +60.0% | 3.81% | +241.1% |
| Q3 2014 | $5,375,000 | -14.6% | 1,527,000 | +15.9% | 1.12% | +12.2% |
| Q2 2014 | $6,295,000 | +527.0% | 1,317,000 | +1145.9% | 1.00% | +537.8% |
| Q1 2014 | $1,004,000 | -93.5% | 105,705 | -95.5% | 0.16% | -94.2% |
| Q4 2013 | $15,398,000 | +18.0% | 2,368,905 | +37.8% | 2.69% | +20.0% |
| Q3 2013 | $13,046,000 | – | 1,718,905 | – | 2.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |